MedTrace Logo

Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)

NCT03374345 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-09-01

No results posted yet for this study

Summary

Gachon University, Gil Oriental Medicine Center

Conditions

  • Cold Hypersensitivity

Interventions

DRUG

Sipjeondaebo-tang Granule

3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

DRUG

Placebo

3g, three times a day, each taken before or between meals Manufacturing company: HANPOONG PHARM \& FOODS Co. Ltd.

Sponsors & Collaborators

  • Kyunghee University Medical Center

    collaborator OTHER

  • Kyung Hee University Hospital at Gangdong

    collaborator OTHER

  • Semyung University Affiliated Oriental Medical Hospital

    collaborator OTHER

  • Sangji University Oriental Medical Hospital

    collaborator UNKNOWN

  • Gachon University Gil Oriental Medical Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2019-12-30
Completion
2019-12-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03374345 on ClinicalTrials.gov